Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.ATI announces sale of precision rolled strip operations to Ulbrich
ATI Physical Therapy Reports Third Quarter 2024 Results
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
ATI's Earnings Miss Estimates in Q3, Revenues Increase Y/Y
ATI Inc (ATI) Q3 2024 Earnings Call Transcript
Allegheny Technologies (ATI) Q3 Earnings and Revenues Lag Estimates
ATI Announces Third Quarter 2024 Results
Allegheny Technologies (ATI) Reports Next Week: Wall Street Expects Earnings Growth
ATI Physical Therapy to Announce Third Quarter 2024 Financial Results
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
Allegheny Technologies (ATI) Exceeds Market Returns: Some Facts to Consider
See Democracy in Action: Allegheny County High Schools Conduct Voter Registration Drives This Week
Allegheny Technologies (ATI) Stock Declines While Market Improves: Some Information for Investors
Allegheny Technologies (ATI) Stock Sinks As Market Gains: Here's Why
ATI Announces Webcast for Third Quarter 2024 Results
Allegheny Technologies (ATI) Stock Dips While Market Gains: Key Facts
Allegheny Technologies (ATI) Declines More Than Market: Some Information for Investors
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
Allegheny Technologies (ATI) Stock Falls Amid Market Uptick: What Investors Need to Know
Why Is Allegheny Technologies (ATI) Up 0.7% Since Last Earnings Report?
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.